Skip to main content

Table 1 Patient demographics and disease characteristics

From: Comparison of concurrent chemoradiotherapy versus neoadjuvant chemotherapy followed by radiation in patients with advanced nasopharyngeal carcinoma in endemic area: experience of 128 consecutive cases with 5 year follow-up

  CCRT group (n = 90)   NACT group (n = 38)   P-value
Characteristics No. % No. %  
Age, years      0.95
 Range 15.7 - 81.5   22.9 - 73.0   
 Median 48.2   48.2   
 Mean 47.9   47.8   
Gender      0.347
 Male 73 81.1 28 73.7  
 Female 17 18.9 10 26.3  
WHO Classification      0.941
 Type I 4 4.4 2 5.3  
 Type II 31 34.4 12 31.6  
 Type III 55 61.1 24 63.2  
T stage      0.200
 T1 to T2 56 62.2 19 50  
 T3 to T4 34 37.8 19 50  
N stage      0.029
 N0 to N1 29 32.2 5 13.2  
 N2 to N3 61 67.8 33 86.8  
Overall Stage      0.002
 IIB-III 66 73.3 17 44.8  
 IVA-IVB 24 26.7 21 55.2  
  1. CCRT, concurrent chemoradiotherapy; NACT, neoadjuvant chemotherapy followed by radiotherapy; WHO, World Health Organization.